Title: Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial
for predicting the prognosis of gastric adenocarcinoma
Version: 2 Date: 10 Jun 2021
Reviewer's report:
Wang et al investigated that  gastric adenocarcinoma cases with definite sAFP levels and then
analyzed their clinicopathological characteristics and immunohistochemical results of AFP,
GPC3, and SALL4. They determined the value of sAFP and A/G/S-IHC in the diagnosis and
treatment of gastric adenocarcinoma.  The manuscript is well illustrated that the conclusions
supported by the evidence presented and the methods sufficiently described to allow the study
to be repeated.
Title: Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial
for predicting the prognosis of gastric adenocarcinoma
Version: 2 Date: 10 Jun 2021
Reviewer's report:
Wang et al investigated that  gastric adenocarcinoma cases with definite sAFP levels and then
analyzed their clinicopathological characteristics and immunohistochemical results of AFP,
GPC3, and SALL4. They determined the value of sAFP and A/G/S-IHC in the diagnosis and
treatment of gastric adenocarcinoma.  The manuscript is well illustrated that the conclusions
supported by the evidence presented and the methods sufficiently described to allow the study
to be repeated.
Please review this paper.
user
Title: Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial
for predicting the prognosis of gastric adenocarcinoma
Version: 2 Date: 10 Jun 2021
Reviewer's report:
Wang et al investigated that  gastric adenocarcinoma cases with definite sAFP levels and then
analyzed their clinicopathological characteristics and immunohistochemical results of AFP,
GPC3, and SALL4. They determined the value of sAFP and A/G/S-IHC in the diagnosis and
treatment of gastric adenocarcinoma.  The manuscript is well illustrated that the conclusions
supported by the evidence presented and the methods sufficiently described to allow the study
to be repeated.
assistant